We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+7.83%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$853M
AUM Growth
+$41.2M
Cap. Flow
-$4.27M
Cap. Flow %
-0.5%
Top 10 Hldgs %
45.97%
Holding
2,993
New
166
Increased
1,040
Reduced
961
Closed
220

Sector Composition

Rank Sector Weight
1 Financials 17.04%
2 Technology 13.3%
3 Healthcare 7.37%
4 Industrials 3.43%
5 Consumer Staples 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MJ icon
1826
Amplify Alternative Harvest ETF
MJ
$105M
$5.33K ﹤0.01%
126
+21
+20% +$1.04K
HLX icon
1827
Helix Energy Solutions
HLX
$1.41B
$5.32K ﹤0.01%
687
-66
-9% -$516
HBI
1828
DELISTED
Hanesbrands
HBI
$5.31K ﹤0.01%
1,009
+452
+81% +$2.84K
HEI.A icon
1829
HEICO Corp Class A
HEI.A
$37.2B
$5.3K ﹤0.01%
39
KREF
1830
KKR Real Estate Finance Trust
KREF
$499M
$5.29K ﹤0.01%
464
+147
+46% +$2.06K
AUY
1831
DELISTED
Yamana Gold, Inc.
AUY
$5.26K ﹤0.01%
900
JELD icon
1832
JELD-WEN Holding
JELD
$164M
$5.25K ﹤0.01%
415
+127
+44% +$1.57K
XLB icon
1833
State Street Materials Select Sector SPDR ETF
XLB
$8.66B
$5.24K ﹤0.01%
130
+108
+491% +$4.37K
UTAAU
1834
DELISTED
UTA Acquisition Corporation Units
UTAAU
$5.24K ﹤0.01%
500
GNK icon
1835
Genco Shipping & Trading
GNK
$1.1B
$5.21K ﹤0.01%
333
-12
-3% -$205
NGM
1836
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$5.21K ﹤0.01%
1,278
+231
+22% +$1.07K
NHI icon
1837
National Health Investors
NHI
$3.65B
$5.21K ﹤0.01%
101
+95
+1,583% +$5.18K
FHI icon
1838
Federated Hermes
FHI
$4.72B
$5.18K ﹤0.01%
129
EGRX
1839
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$5.16K ﹤0.01%
182
-95
-34% -$2.82K
SEE
1840
DELISTED
Sealed Air
SEE
$5.14K ﹤0.01%
112
+3
+3% +$149
VMI icon
1841
Valmont Industries
VMI
$9.53B
$5.11K ﹤0.01%
16
REVG
1842
DELISTED
REV Group
REVG
$5.1K ﹤0.01%
+425
New +$5.29K
BRFS
1843
DELISTED
BRF SA
BRFS
$5.07K ﹤0.01%
3,962
-89
-2% -$125
RLI icon
1844
RLI Corp
RLI
$5.89B
$5.05K ﹤0.01%
76
H icon
1845
Hyatt Hotels
H
$16.7B
$5.03K ﹤0.01%
45
WH icon
1846
Wyndham Hotels & Resorts
WH
$5.48B
$5.02K ﹤0.01%
74
+4
+6% +$295
BLD
1847
DELISTED
TopBuild
BLD
$5K ﹤0.01%
24
+20
+500% +$3.87K
SNCY
1848
DELISTED
Sun Country Airlines
SNCY
$4.98K ﹤0.01%
243
+2
+0.8% +$39
SNEX icon
1849
StoneX
SNEX
$7.94B
$4.97K ﹤0.01%
243
-46
-16% -$875
TGTX icon
1850
TG Therapeutics
TGTX
$7.62B
$4.96K ﹤0.01%
330
+27
+9% +$410

Similar funds

Lindbrook Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Lindbrook Capital held 2,993 positions worth $853M, up 5.1% from $812M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital's Q1 2023 filing shows 166 new, 1,040 increased, 961 reduced and 220 closed positions. Its largest new stake was Hess Midstream: 4,984 shares worth $144K. The largest sale was Oramed Pharmaceuticals, an estimated $4.61M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • Lindbrook Capital's largest Q1 2023 buy was Hess Midstream: 4,984 shares worth $144K.
  • Lindbrook Capital added most to Vanguard Total International Stock ETF in Q1 2023, an estimated $12.7M increase.
  • Lindbrook Capital's biggest Q1 2023 reduction was Agenus, cutting an estimated $2.89M.
  • Lindbrook Capital fully exited Oramed Pharmaceuticals in Q1 2023, selling an estimated $4.61M.
  • Lindbrook Capital's ten largest holdings make up 46% of its $853M portfolio in Q1 2023.
  • Lindbrook Capital opened 166 new positions and closed 220 in Q1 2023.
  • Lindbrook Capital's portfolio value rose 5.1% quarter-over-quarter to $853M.

Based on Lindbrook Capital's 13F filing for Q1 2023, filed 26 Apr 2023.